MoneyWorks4Me

FDC - Quaterly Results

06 Nov 2024 Evaluate
The revenue for the September 2024 quarter is pegged at Rs. 5051.04 millions, about 5.30% up against Rs. 4796.98 millions recorded during the year-ago period.Profit for the quarter ended September 2024 increased merely by2.68% to Rs. 739.73  millions from Rs. 720.41 millions.OP of the company witnessed a marginal growth to 1070.78 millions from 1060.95 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5051.04 4796.98 5.30 11292.45 10097.38 11.84 19161.87 17770.32 7.83
Other Income 346.78 273.85 26.63 628.31 571.69 9.90 1032.16 539.12 91.45
PBIDT 1070.78 1060.95 0.93 2769.24 2558.85 8.22 4416.74 3084.87 43.17
Interest 10.71 10.51 1.90 23.63 20.89 13.12 40.00 40.39 -0.97
PBDT 1060.07 1050.44 0.92 2745.61 2537.96 8.18 4376.74 3044.48 43.76
Depreciation 137.58 98.13 40.20 247.53 194.01 27.59 397.29 387.58 2.51
PBT 922.49 952.31 -3.13 2498.08 2343.95 6.58 3979.45 2656.90 49.78
TAX 182.76 231.90 -21.19 608.46 538.03 13.09 907.82 647.25 40.26
Deferred Tax -17.24 16.71 -203.17 48.46 17.84 171.64 51.63 -42.75 -220.77
PAT 739.73 720.41 2.68 1889.62 1805.92 4.63 3071.63 2009.65 52.84
Equity 162.81 162.81 0.00 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 21.20 22.12 -4.15 24.52 25.34 -3.23 23.05 17.36 32.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..